APA (7th ed.) Citation
Kobayashi, T., Kitamura, H., Furukawa, Y., Kambe, A., Shono, M., Ito, T., & Kikuchi, E. (2/10/2025 Supplement5). Evaluation of avelumab first-line (1L) maintenance therapy and subsequent treatment (tx) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) using a large claims database in Japan: JAVEMACS-D. Journal of Clinical Oncology, 43, 700-942.
Chicago Style (17th ed.) Citation
Kobayashi, Takashi, Hiroshi Kitamura, Yuka Furukawa, Anzu Kambe, Michihiro Shono, Takayuki Ito, and Eiji Kikuchi. "Evaluation of Avelumab First-line (1L) Maintenance Therapy and Subsequent Treatment (tx) in Patients (pts) with Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Using a Large Claims Database in Japan: JAVEMACS-D." Journal of Clinical Oncology 43 (2/10/2025 Supplement5): 700-942.
MLA (9th ed.) Citation
Kobayashi, Takashi, et al. "Evaluation of Avelumab First-line (1L) Maintenance Therapy and Subsequent Treatment (tx) in Patients (pts) with Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Using a Large Claims Database in Japan: JAVEMACS-D." Journal of Clinical Oncology, vol. 43, 2/10/2025 Supplement5, pp. 700-942.
Warning: These citations may not always be 100% accurate.